In 2024, the United States has cemented its role as the world’s leading driver of natural gas demand, with power producers significantly increasing gas-fired generation. Over the first nine ...

Investors might want to bet on Essex Property Trust (ESS), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

For Adverum Biotechnologies, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this ...

In one of our recent articles about 8 Most Undervalued Penny Stocks To Buy According To Analysts, we talked about how many ...

Announcement comes ahead of the first anniversary of Nasdaq’s acquisition of AdenzaNasdaq also wins two awards for its financial crime management ...

We recently compiled a list of the Jim Cramer on the Magnificent Seven Stocks Plus Netflix. In this article, we are going to ...

So, the natural question for ORIC Pharmaceuticals (NASDAQ:ORIC) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) ...

Wave Life Sciences' WVE-006 study shows significant promise in treating alpha-1 antitrypsin deficiency. Learn more about WVE ...

Today we're going to take a look at the well-established Lam Research Corporation ( NASDAQ:LRCX ). The company's ...

Celularity Inc. (Nasdaq: CELU) ('Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of placental-derived advanced biomaterial ...

These two companies are often seen as front-runners in the artificial intelligence (AI) arms race, so why are their stocks ...

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound(TM) Product from Sequence LifeScience, Inc.